CEP vs THAR
Comparison between Cantor Equity Partners Inc - Class A (CEP, Company) and Tharimmune Inc (THAR, Company).
CEP is from the Financial Services sector, while THAR is from the Healthcare sector.
CEP vs THAR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
CEP vs THAR - Historical Returns
Returns include dividend reinvestment.
CEP vs THAR - Annual Returns (2022 - 2026)
Returns include dividend reinvestment.
| Year | CEP | THAR |
|---|---|---|
| 2026 | +0.00% | -29.88% |
| 2025 | +37.34% | +47.80% |
| 2024 | +3.80% | -73.20% |
| 2023 | N/A | -94.03% |
| 2022 | N/A | -88.80% |
CEP vs THAR Drawdown Comparison
The maximum drawdown for CEP was -77.58%, occurring on Dec 1, 2025. This drawdown has not yet recovered.
The maximum drawdown for THAR was -99.93%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The current CEP drawdown is -71.46%. The current THAR drawdown is -99.85%.
| Rank | CEP | THAR |
|---|---|---|
| #1 | -77.58% May 1, 2025 - Dec 1, 2025 | -99.93% Feb 2, 2022 - Apr 9, 2025 |
| #2 | -3.40% Dec 23, 2024 - Mar 26, 2025 | -26.15% Jan 12, 2022 - Jan 24, 2022 |
| #3 | -1.85% Apr 10, 2025 - Apr 23, 2025 | -2.13% Jan 24, 2022 - Jan 27, 2022 |
| #4 | -1.40% Apr 25, 2025 - Apr 29, 2025 | -1.87% Jan 31, 2022 - Feb 2, 2022 |
| #5 | -1.27% Dec 16, 2024 - Dec 23, 2024 | N/A |
| #6 | -0.87% Nov 20, 2024 - Dec 2, 2024 | N/A |
| #7 | -0.74% Apr 1, 2025 - Apr 10, 2025 | N/A |
| #8 | -0.58% Dec 2, 2024 - Dec 12, 2024 | N/A |
| #9 | -0.40% Oct 25, 2024 - Nov 8, 2024 | N/A |
| #10 | -0.32% Aug 22, 2024 - Sep 24, 2024 | N/A |
| #11 | -0.20% Aug 13, 2024 - Aug 21, 2024 | N/A |
| #12 | -0.20% Sep 24, 2024 - Oct 21, 2024 | N/A |
| #13 | -0.20% Oct 21, 2024 - Oct 25, 2024 | N/A |
| #14 | -0.10% Nov 18, 2024 - Nov 20, 2024 | N/A |
| #15 | -0.10% Dec 12, 2024 - Dec 16, 2024 | N/A |
Correlation
Correlation between CEP and THAR is -0.12 which considered as a very weak or no correlation - the stocks move independently of each other.
Select Stocks to Compare
More Comparisons
Compare with similar stocks